跳至主要内容
临床试验/NCT04904653
NCT04904653招募中4 期

Randomized Controlled and Single Blind Clinical Trial in Women With Breast Cancer and Axillary Lymphadenectomy, to Evaluate the Effectiveness of Hemopatch® in the Reduction of Post-surgical Serous Drainage

Instituto de Investigación Hospital Universitario La Paz2 个研究点 分布在 1 个国家目标入组 118 人开始时间: 2021年11月8日最近更新:
适应症
干预措施

试验速览

阶段
4 期
状态
招募中
入组人数
118
试验地点
2
主要终点
Total volume in milliliters (ml) of drainage

研究概览

简要总结

Hemopatch is an alternative to reduce morbidity associated with axillary lymphadenectomy surgery, possibly contributing to improved patient management, clinical outcomes, and hospital costs. We propose a multicenter, controlled, and randomized trial to study the efficacy of Hemopatch in reducing serous wound drainage.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Other
盲法
Single (Participant)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • 未提供

排除标准

  • 未提供

研究组 & 干预措施

Hemopatch Group:

Experimental

Hemopatch + suction drainage

干预措施: Hemopatch (Device)

Control group

Other

No sealant (liquid, gel or patch) + suction drain

干预措施: Control group (Other)

结局指标

主要结局

Total volume in milliliters (ml) of drainage

时间窗: In the last 24 hours

Total volume in milliliters (ml) of drainage: To be measured in the hospital every day before discharge, and collected daily after discharge with a follow-up of phone calls or patient diaries during hospital visits until extraction drain.

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验